Mol Microbiol 2006, 59:142–151 PubMedCrossRef 71 Mikuniya T, Kat

Mol Microbiol 2006, 59:142–151.PubMedCrossRef 71. Mikuniya T, Kato Y, Kariyama R, Monden K, Hikida M, Kumon H: Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta Med Okayama 2005, 59:209–216.PubMed 72. Norris P, Noble M, Francolini I, Vinogradov AM, Stewart PS, Ratner BD, Costerton JW, Stoodley P: Ultrasonically controlled release of ciprofloxacin from self-assembled coatings Acalabrutinib cell line on poly(2-hydroxyethyl methacrylate) hydrogels for Pseudomonas aeruginosa biofilm prevention. Antimicrob Agents Chemother 2005, 49:4272–4279.PubMedCrossRef 73. Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell

S, Elkins M, Thompson B, Macleod C, Aaron SD, see more et al.: selleck inhibitor Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol 2005, 43:5085–5090.PubMedCrossRef 74. Marques CN, Salisbury VC, Greenman J, Bowker KE, Nelson SM: Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas

aeruginosa biofilms. J Antimicrob Chemother 2005, 56:665–671.PubMedCrossRef 75. Bjarnsholt T, Jensen PØ, Burmølle M, Hentzer M, Haagensen JA, Hougen H-P, Calum H, Madsen KG, Moser C, Molin S, et al.: Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependant. Microbiology 2005, 151:373–383.PubMedCrossRef 76. Moskowitz SM, Foster JM, Emerson J, Burns JL: Clinically feasible biofilm suceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004, 42:1915–1922.PubMedCrossRef 77. Brooun A, Liu S, Lewis K: A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother

2000, 44:640–646.PubMedCrossRef 78. Goto T, Nakame Y, Nishida M, Ohi Y: In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology 1999, 53:1058–1062.PubMedCrossRef 79. Coquet L, Junter GA, Jouenne T: Resistance of artificial biofilms of Pseudomonas aeruginosa CYTH4 to imipenem and tobramycin. J Antimicrob Chemother 1998, 42:755–760.PubMedCrossRef 80. Yassien M, Khadori N, Ahmedy A, Toama M: Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob Agents Chemother 1995, 39:2262–2268.PubMed 81. Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW: Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aerginosa biofilms. Antimicrob Agents Chemother 1995, 39:1281–1286.PubMed 82. Anwar H, Strap JL, Chen K, Costerton JW: Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 1992, 36:1208–1214.PubMed 83.

Comments are closed.